HealthEquity Inc (HQY) — the peer cohort

As of 2026-10-12 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

HealthEquity Inc ranks 5 of 9 in its cohort on the Closelooknet composite (61/100) — the cohort is led by Halozyme Therapeutics Inc at 74/100.

Name	Composite	Momentum	Quality	Valuation	Signal	Off 52w high
HQY HealthEquity Inc	61	62	69	43	info	14.5%
VEEV Veeva Systems Inc Class A	61	95	74	29	bull	4.6%
HNGE Hinge Health, Inc.	56	96	63	24	ok	0.1%
BTSG BrightSpring Health Services, Inc. Common Stock	48	64	25	37	ok	14.6%
TEM Tempus AI, Inc. Class A Common Stock	39	70	18	14	bull	32%
HALO Halozyme Therapeutics Inc	74	94	94	48	ok	4.9%
DXCM DexCom Inc	66	85	80	35	bull	9.2%
ONC BeiGene, Ltd.	63	76	62	30	info	9%
MEDP Medpace Holdings Inc	63	85	74	28	ok	8.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-10-12

Quick answers

Who are HealthEquity Inc's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: Veeva Systems Inc Class A (VEEV), Hinge Health, Inc. (HNGE), BrightSpring Health Services, Inc. Common Stock (BTSG), Tempus AI, Inc. Class A Common Stock (TEM), Halozyme Therapeutics Inc (HALO), DexCom Inc (DXCM), BeiGene, Ltd. (ONC), Medpace Holdings Inc (MEDP).

How does HQY score against its peers?

HealthEquity Inc's composite reads 61/100, ranking 5 of 9 in its cohort as of 2026-10-12; the cohort's highest composite is Halozyme Therapeutics Inc at 74/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Health Information Services, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.